Literature DB >> 19215788

Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits.

Tae Sung Park1, Seung Tae Lee, Jaewoo Song, Kyung-A Lee, Jong-Han Lee, Juwon Kim, Hyeon-Ji Lee, Jeong-Hyun Han, Jong-Kee Kim, Sung Ran Cho, Jong Rak Choi.   

Abstract

We report on a 20-year-old man with acute myeloid leukemia (AML) showing a distinct novel CBFB/MYH11 variant fusion transcript. Initial results of bone marrow, chromosome, and flow cytometric analyses were not in accordance with the diagnosis of acute myelomonocytic leukemia with eosinophilia (AML-M4Eo) or AML with a CBFB/MYH11 rearrangement. However, results from 2 commercially available multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) tests repeatedly showed an unusual PCR product from his bone marrow specimen. Not only does this case show a partial insertion of exon 6 of the CBFB (ENSG00000067955) gene, but it also involves novel breakpoints within both exon 6 of the CBFB gene and exon 28 (previously exon 7) of the MYH11 (ENSG00000133392) gene, which is regarded as a previously non-reported, new type (K-type) of CBFB/MYH11 fusion transcript. In addition, our study result was in agreement with the recent report of Schnittger et al. that rare fusion transcripts of CBFB/MYH11 are correlated with an atypical cytomorphology and other aberrant characteristics. Therefore, multiplex RT-PCR and sequence analysis of these atypical products should be performed to diagnose atypical AML with CBFB/MYH11 rearrangement, to predict prognosis of these patients as well as to elucidate the molecular mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19215788     DOI: 10.1016/j.cancergencyto.2008.10.012

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.

Authors:  Sebastian Schwind; Colin G Edwards; Deedra Nicolet; Krzysztof Mrózek; Kati Maharry; Yue-Zhong Wu; Peter Paschka; Ann-Kathrin Eisfeld; Pia Hoellerbauer; Heiko Becker; Klaus H Metzeler; John Curfman; Jessica Kohlschmidt; Thomas W Prior; Jonathan E Kolitz; William Blum; Mark J Pettenati; Paola Dal Cin; Andrew J Carroll; Michael A Caligiuri; Richard A Larson; Stefano Volinia; Guido Marcucci; Clara D Bloomfield
Journal:  Blood       Date:  2012-11-16       Impact factor: 22.113

2.  Diagnostic standardization of leukemia fusion gene detection system using multiplex reverse transcriptase-polymerase chain reaction in Korea.

Authors:  Min Jin Kim; Jong Rak Choi; Jin-Tae Suh; Hee Joo Lee; Woo-In Lee; Tae Sung Park
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

3.  Acute myeloid leukemia with inv(16)(p13.1q22) and deletion of the 5'MYH11/3'CBFB gene fusion: a report of two cases and literature review.

Authors:  Lili Lv; Jingwei Yu; Zhongxia Qi
Journal:  Mol Cytogenet       Date:  2020-01-30       Impact factor: 2.009

4.  Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report.

Authors:  Wenyi Zhang; Hainan Wang; Peilei Zhang; Hongliang Li; Xiaoli Ma; Hongxing Liu
Journal:  Braz J Med Biol Res       Date:  2021-10-29       Impact factor: 2.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.